The Comparative Effectiveness of First-Line Tumor Necrosis Factor Inhibitor (TNFi) Compared with Non-TNFi Agents in Patients with Rheumatoid Arthritis: Results from the Corrona Registry

被引：0
|
作者：
Pappas, Dimitrios A. [1 ]
St John, Gregory [2 ]
Etzel, Carol J. [1 ]
Fiore, Stefano [3 ]
Blachley, Taylor [1 ]
Kimura, Toshio [2 ]
Punekar, Rajeshwari [3 ]
Emeanuru, Kelechi [1 ]
Boklage, Susan [2 ]
Kremer, Joel [1 ,4 ,5 ]
机构：
[1] Corrona LLC, Waltham, MA USA
[2] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[3] Sanofi, Bridgewater, NJ USA
[4] Albany Med Coll, Albany, NY 12208 USA
[5] Ctr Rheumatol, Albany, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2877
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Comparative Effectiveness of Tocilizumab (TCZ) Monotherapy with Tumor Necrosis Factor Inhibitors (TNFi) in Combination with Varying Doses of Methotrexate (MTX) in Patients with Rheumatoid Arthritis
    Harrold, Leslie R.
    Reed, George W.
    Best, Jennie
    Zlotnick, Steve
    Persuitte, Gioia
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [22] Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng et al
    Pappas, Dimitrios A.
    St John, Gregory
    Etzel, Carol J.
    Fiore, Stefano
    Blachley, Taylor
    Kimura, Toshio
    Punekar, Rajeshwari
    Emeanuru, Kelechi
    Choi, Jeannie
    Boklage, Susan
    Kremer, Joel M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11)
  • [23] COMPARATIVE EFFECTIVENESS OF TOCILIZUMAB (TCZ) MONOTHERAPY WITH TUMOR NECROSIS FACTOR INHIBITORS (TNFI) IN COMBINATION WITH VARYING DOSES OF METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Harrold, L. R.
    Reed, G. W.
    Best, J.
    Zlotnick, S.
    Persuitte, G.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1191 - 1192
  • [24] Comparative Effectiveness Of Rituximab Vs. Subsequent Anti-Tumor Necrosis Factor In Patients With Rheumatoid Arthritis With Prior Exposure To TNFi.
    Harrold, Leslie R.
    Reed, George W.
    Magner, Robert P.
    Shewade, Ashwini
    John, Ani
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S610 - S610
  • [25] Discontinuation of TNFi Treatment Among Rheumatoid Arthritis Patients with a Molecular Signature of Non-response to Tumor Necrosis Factor-α Inhibitor Therapies
    Curtis, Jeffrey
    Kremer, Joel
    Pappas, Dimitrios
    Zhang, Lixia
    Connolly-Strong, Erin
    Withers, Johanna
    Akmae, Viatcheslav
    Saleh, Alif
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2589 - 2590
  • [26] Cardiovascular and Cancer Safety of JAKi Compared to TNFi in Patients with Rheumatoid Arthritis: Results from a National Registry of Advanced Therapies
    Otero-Varela, Lucia
    Sanchez-Piedra, Carlos
    Rubio, Elena Rabadan
    Sarmiento-Monroy, Juan Camilo
    Plasencia-Rodriguez, Chamaida
    Sueiro, Diana
    Martinez, Olga
    Busquets Perez, Noemi
    Freire Gonzalez, Mercedes
    Sanchez-Alonso, Fernando
    Alvaro-Gracia, Jose Maria
    Castrejon, Isabel
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4574 - 4576
  • [27] Discontinuation and Switching Patterns By TNFi Line of Therapy in Patients with Psoriatic Arthritis-Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
    Mease, Philip J.
    Karki, Chitra
    Liu, Mei
    Li, YouFu
    Hur, Peter
    Greenberg, Jeffrey D.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [28] COMPARATIVE EFFECTIVENESS OF RITUXIMAB VERSUS SUBSEQUENT ANTI-TUMOR NECROSIS FACTOR IN CUMULATIVE PREDNISONE EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH PRIOR EXPOSURE TO TNFI
    Harrold, L.
    Reed, G.
    Magner, R.
    Shewade, A.
    John, A.
    Greenberg, J.
    Kremer, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 508 - 508
  • [29] Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registry
    Mease, Philip J.
    Karki, Chitra
    Liu, Mei
    Li, YouFu
    Gershenson, Bernice
    Feng, Hua
    Hur, Peter
    Greenberg, Jeffrey D.
    RMD OPEN, 2019, 5 (01):
  • [30] A COMPARATIVE EFFECTIVENESS STUDY OF ABATACEPT AND TNFI AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS USING REAL-WORLD DATA
    Alemao, Evo
    Connolly, Sean
    Elbez, Yedid
    Rao, Aarti
    Saini, Yogesh
    Iannaccone, Christine
    Weinblatt, Michael E.
    Shadick, Nancy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1646 - 1647
12345